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Background. Growth guidance sliding treatment devices such as Shilla 7 
(Medtronic, USA) or LSZ-4D (Conmet, Russia) used for the treatment of 8 
scoliosis in children who have high growth potential have unlocked fixtures 9 
allowing rods to slide during growth of the spine which avoids periodical 10 
extensions. However, the probability of clinical complications associated with 11 
metallosis after the implantation of such devices is poorly understood. The 12 
content of metal ions in the blood and tissues of pediatric patients treated for 13 
scoliosis using fusionless growth guidance sliding instrumentation, have not yet 14 
been investigated. 15 
Purpose. The aim of this study was to measure the content of metal ions in 16 
blood and tissues surrounding implanted growth guidance sliding LSZ-4D 17 
devices made of titanium alloy (Ti6Al4V) and to identify the incidence  of 18 
metallosis associated clinical complications in some patients with these devices. 19 
Study design. One center case-control retrospective study. 20 
Patients sample. Study group included 25 patients with high growth potential (3 21 
males, 22 females, average age at primary surgery for scoliosis treatment is 22 
11.4±1.2 years old) who had sliding growth guidance instrumentation LSZ-4D 23 
(Conmet, Moscow, Russia) implanted on 13 (range 10-16) spine levels for 6±2 24 
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 3 
years. The LSZ-4D device was made from titanium alloy Ti6Al4V and consisted 1 
of two rectangular section rods and fixture elements. Locked fixtures were used 2 
on one spinal level, while the others were unlocked (sliding).  The control group 3 
consisted of 13 patients (12 females and 1 male, 11±1.2 years old) without any 4 
implanted devices. 5 
Outcome measures. The content of Ti, Al and V metal ions in the whole blood 6 
and tissues around the implanted device was measured. Incidence of metallosis 7 
associated complications in the study group were recorded.  8 
Methods. Metal ion content was measured by ICP-MC on quadrupolar Nexion 9 
300D (Perkin Elmer, USA). 10 
Results. 5 of 25 patients in the study group developed metallosis associated 11 
complications (two sinuses and three seromas in the lumbar part of the spine). 12 
Revisions were carried out in two of these patients. 90% of patients in the study 13 
group had increased content of Ti and V ions in the blood (2.8 and 4 times 14 
respectively). Median content of Ti ions in soft tissues adjacent to implanted 15 
sliding device was more than 1,500 fold higher compared with  the control 16 
group. These levels are much higher than previously reported for spinal 17 
instrumentation. 18 
Conclusion. Increased content of Ti and V ions in the blood and especially in 19 
tissues around the titanium growth guidance sliding device LSZ-4D 20 
accompanied by clinical manifestations (seromas and sinuses) indicate the 21 
importance of improving of wear resistance of such instrumentation with the 22 
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 4 
coatings and the necessity to exchange sliding instrumentation once the child is 1 
fully grown. 2 
Introduction 3 
Fusionless instrumentation enabling growth of the spine is used for early 4 
onset scoliosis treatment or for the treatment of adolescent scoliosis in case of 5 
high growth potential in order to avoid early fusion in pediatric patients. 6 
Mechanically or magnetically extendable rods are widely used for this purpose 7 
[1-2].  These extendable growing rods require intermittent extension (at least 8 
twice a year). Long-term complication of proximal junction kyphosis is another 9 
drawback of these devices [3]. In growth guidance sliding instrumentation such 10 
as Shilla (Medtronic, USA) or LSZ-4D (Conmet, Russia) unlocked fixtures are 11 
used allowing the rods to slide during growth of the child’s spine, thus avoiding 12 
periodical extensions [4-5].  13 
Potentially as these rods slide in the guiding fixtures excessive metal 14 
debris (metallosis) could be generated. Metallosis associated with CoCr debris 15 
generated at the articulation of metal-on-metal total hip prosthesis is associated 16 
with pseudotumors and sensitivity to metal debris and is the main reason for the 17 
revision of these implants [6]. Excessive amounts of more biologically 18 
compatible Ti wear debris produced by spinal implants have been reported to 19 
cause inflammation and osteolysis in animal experiments [7-9]. A case report 20 
identifying wear debris induced osteolysis around a pedicle screw after posterior 21 
spine fusion in a pediatric patient has recently been reported [10]. 22 
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 5 
However, the probability of clinical complications associated with 1 
metallosis after implantation of fusionless growth guidance sliding spinal 2 
instrumentation is poorly understood since these devices have been recently 3 
released. The question of changing of other fusionless instrumentation into a 4 
more traditional fusion device after child’s growth has stopped has not yet been 5 
addressed also since there are no long-term follow-up studies with such spinal 6 
instrumentation.  7 
Extensive analysis of wear damage of total hip and knee replacements 8 
(THP and TKR) revealed that excessive debris release is normally accompanied 9 
by the increasing metal ion levels in the patients’ whole blood and serum [11-10 
12]. Increases of titanium ion levels in the blood of patients with implanted 11 
titanium spinal instrumentation was reported by Cundy et al [13], Kasai et al 12 
[14] and Richardson et al [15], even in arthrodesis procedures. Elevated titanium 13 
ion concentration of up to 50 times normal levels was observed by Wang et al. 14 
in tissues surrounding spinal implants [16].  15 
However, the content of metal ions in the blood and tissues of pediatric 16 
patients treated using fusionless, especially growth guidance sliding 17 
instrumentation, have not yet been investigated. The aim of our study was to 18 
measure the content of metal ions in blood and tissues surrounding implanted 19 
growth guidance sliding LSZ-4D devices made of titanium alloy (Ti6Al4V) and 20 
to identify the incidence of metallosis associated clinical complications in some 21 
patients with these devices. It was hypothesized that the level of metal ions in 22 
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 6 
the blood and tissues of patients after implantation of sliding growth guidance 1 
instrumentation would be higher compared to data previously reported for 2 
traditional fusion spinal devices. 3 
Methods  4 
Study design and participants 5 
This is one center case-control retrospective study.  6 
25 patients (3 males and 22 females having high growth potential, average 7 
age at primary surgery is 11.4±1.2 years old) who had sliding growth guidance 8 
instrumentation LSZ-4D (Conmet, Moscow, Russia) implanted for  6±2 years 9 
were recruited into the study group for the measurements of metal ion content in 10 
their whole blood and tissues. Recruitment was carried out in the Center for 11 
Scoliosis Correction, Medical Department of the Peoples’ Friendship University 12 
of Russia (Moscow, Russian Federation) from May to October 2013. These 13 
patients were undergoing the routine surgery of exchanging of sliding LSZ-4D 14 
devices with traditional fusion instrumentation when they became skeletally 15 
mature (second surgery).  16 
LSZ-4D sliding instrumentation was made from titanium alloy Ti6Al4V 17 
(Ti-6wt. %Al-4wt. %V) and consisted of two rectangular section rods (6x4mm) 18 
and 40±8 fixture elements (20±4 hooks and 20±4 clips). Locked fixtures were 19 
used on one spinal level. Other fixtures were unlocked (sliding) thus enabling 20 
sliding and continued spinal growth (Figure 1). The device was implanted on 13 21 
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 7 
(range 10-16) spine levels for 6±2 years (Table 1). According to Lenke 1 
classification [17] patients in the study group had the following scoliosis types:  2 
1 – IA+; 1 – IBN; 7 – IIBN; 7 – IIIBN; 7 – IIICN; 1 – IVCN; 1 –VCN. 3 
Approximately 80-90% of correction was achieved for patients having initial 4 
Cobb’s angle less than 60 (n=8), while 70-78% of correction was observed for 5 
those with initial Cobb angle more than 60 (n=17). 6 
For the measurements of Ti, Al and V metal ions content the blood was 7 
collected on the day before such routine surgery and tissues around the rod and 8 
screw junction during the surgery. Any incidence of metallosis related 9 
complications in the study group of patients were recorded. 10 
Metal ion levels and tissue analysis were also carried out in a control 11 
group consisting of 13 patients (12 females and 1 male, 11±1.2 years old) with 12 
no implanted devices. These patients were recruited in the same center during 13 
the same period before they had their primary surgery for scoliosis . 14 
Measurement of metal ions in the whole blood and tissues 15 
Content of Ti, Al and V metal ions was measured in the whole blood and 16 
tissues of the study and control groups of patients.  17 
To limit possible contamination venipuncture was performed with 18 
cannula.  Venous blood specimens were collected into the green-cap Vacuette 19 
(sodium heparin containing ) collecting tubes (Greiner Bio-One International 20 
AG,  4550 Kremsmünster, Austria) and diluted 1:30 with an acidified diluents 21 
((v/v) of 1% 1-Butanol, 0.1% Triton X-100 and 0.07 % HNO3 in distilled 22 
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 8 
deionized water (DDIW)).  The amounts of titanium, aluminum and vanadium 1 
were measured using inductively-coupled mass spectrometry method (ICP-MS) 2 
using Nexion 300D ICP-MS spectrometer (PerkinElmer Inc., Shelton, CT 3 
06484, USA).  4 
Soft tissues were taken at the time of surgery from the capsule 5 
surrounding the fixture-rod junction and 3 cm away from the capsule. Tissue 6 
specimens were digested with HNO3 in the Berghof SW-4 DAP-40 microwave 7 
system (Berghof Products + Instruments GmbH, 72800 Eningen, Germany), 8 
diluted 1:150 with DDIW and run into the ICP-MS system within 2-3 hours to 9 
prevent possible precipitation of titanium salts.  10 
Histological examination of tissues was carried out using light microscopy 11 
(Carl Zeiss AXIOSCOP 2 plus microscope). For light microscopy formalin-12 
fixed and paraffin wax embedded sections of 4m thickness were taken and 13 
stained with Hematoxylin and Eosin.  Titanium particles appear black in stained  14 
histological sections and their composition was confirmed using energy 15 
dispersive x-ray analysis.   16 
Statistical methods 17 
The number of patients in the study and control groups (25 and 13 18 
respectively) was calculated using G*Power 3.1.7 software based on the data 19 
from internal pilot study and necessity to check the hypothesis of statistically 20 
significant difference of Ti, Al and V content in blood and tissues at significance 21 
level =0.05 and power 0.95.  22 
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 9 
After metal ion content was measured for all patients the Mann-1 
Whitney U test was used to determine if there was statistically significant 2 
difference in Ti, Al and V content in the blood of patients with implanted LSZ-3 
4D device and those from control group. A p value of less than 0.05 was defined 4 
as statistically significant. This test was chosen after Kolmogorov-Smirnov test 5 
revealed that metal content in blood and tissues significantly deviated from a 6 
normal distribution. This statistical analysis was performed with SPSS 22.0 7 
software (IBM Corp., USA). The same test was carried out for two subgroups of 8 
the study group of patients (those who developed metallosis related 9 
complications and those who did not). Because of the small number of patients 10 
in the subgroup with metallosis complications, power of this test was calculated.  11 
 12 
Results  13 
Metallosis associated complications  14 
Five of 25 patients in the study group who returned to the clinic for the 15 
surgery of exchanging sliding growth guidance titanium LSZ-4D devices with 16 
traditional fusion instrumentation developed metallosis associated complications 17 
in the lumbar part of the spine (Table 1).  18 
Two of such patients required revision surgery because of these 19 
complications. One of these patients developed seroma accompanied with 20 
elevated body temperature and increased erythrocyte sedimentation rate in her 21 
blood which were regarded as signs of inflammation 10 years after the surgery. 22 
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 10 
The second patient developed a sinus with local inflammation 5 years after the 1 
surgery. Clinical symptoms were resolved once the device had been exchanged 2 
or shortened.  In both of the revised cases exhaustive microbiological analysis of 3 
samples taken during s revision surgery using both aerobic and anaerobic 4 
bacterial cultures failed to identify any organisms. 5 
Another three patients developed seromas or sinus without inflammation 6 
0.5 – 2 years after the implantation of LSZ-4D devices (Table 1). However, 7 
these seromas and sinus were successfully treated by compression dressing and 8 
antibiotic therapy and patients were recommended to avoid intensive physical 9 
exercises.  Antibiotic therapy was used as  a precaution to prevent revision 10 
surgery.  11 
Content of metal ions in whole blood 12 
The median values of titanium, aluminum and vanadium in the whole 13 
blood of patients from the control group without implants was 30 ppb (range 30-14 
40) for titanium, 30 ppb (range 20-40) for aluminum and 0.08 ppb (range 0.06-15 
0.1) for vanadium. Patients with implanted LSZ-4D sliding devices had much 16 
higher ion levels with 85 ppb (range 28-180) of titanium, 30 ppb (18-150) of 17 
aluminum and 0.3 ppb (range 0.2-0.5) of vanadium. Statistical analysis using 18 
Mann-Whitney non-parametric test revealed statistically significant (p=0.0001) 19 
raised levels of titanium and vanadium (2.8 and 4 times respectively) in the 20 
whole blood of patients with implanted LSZ-4D devices (Figure 2). However, 21 
content of aluminum in the control and study groups was not statistically 22 
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 11 
significant (p=0.16, power 0.95) due to the variability associated with 1 
aluminium ion content in the study group (Figure 2). 2 
The content of titanium, aluminum and vanadium for patients with 3 
implanted LSZ-4D devices who had seromas and sinuses (n=5) was also 4 
compared with that observed in patients who did not have these complications 5 
(n=20). Statistical analysis revealed no statistically significant difference of 6 
aluminum and vanadium ion content in these groups (p=0.07 and p=0.05 for 7 
aluminum and vanadium respectively). Even slightly lower content of titanium 8 
was revealed in the blood of patients who developed  these metallosis associated 9 
complications (p=0.035). However, because of the small number of patients in 10 
the subgroup of patients with complications (n=5) the power of the test was less 11 
than 0.80 (0.60 for Ti and V ions; 0.10 for Al), which might require further 12 
studies.  13 
Content of metal ions in tissues surrounding implants 14 
Black discoloration of soft tissues adjacent to growth guidance sliding LSZ-4D 15 
devices was observed in all patients, indicating significant amounts of wear 16 
debris (Figure 3).   Median concentration of titanium, aluminum and vanadium 17 
in the soft tissues taken at the time of surgery in patients of control group 18 
operated for scoliosis for the first time and having no metal implants was 0.7  19 
g/g (range 0.15-0.95) for titanium, 0.7  g/g (range 0.1-0.9) for aluminum and 20 
0.06 g/g (range 0.01-0.1) for vanadium.  21 
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Median concentration of these elements in tissues of patients with 1 
implanted growth guidance sliding devices LSZ-4D taken from the capsule 2 
around fixture-rod junction increased dramatically up to 1,300 g/g (range 103 - 3 
5,750) for titanium, 18 g/g (range 2 – 106) for aluminum and 11 g/g (range 2 4 
– 109) for vanadium, indicating statistically significant increase of all elements 5 
(Figure 4). 6 
The concentration of metal ions was measured in soft tissues collected 3 7 
cm away from the capsule indicating  that elevated ions were not just associated 8 
with capsular tissue adjacent to the implant  but were found at a deeper level. 9 
Median values were 6.5 g/g (range 1.3 – 34) for titanium, 0.9 g/g (range 0.4 – 10 
6) for aluminum and 0.1 g/g (0.02 – 0.8) for vanadium, which are significantly 11 
higher compared with control group, but significantly lower compared with 12 
tissues collected from the capsule. 13 
Content of metal ions in the soft tissues adjacent to fixture-rod junction 14 
was also compared for the subgroup of patients with implanted LSZ-4D device 15 
who developed metallosis associated complications (n=5) and those who did not 16 
(n=20). No statistically significant difference was found for any compared 17 
elements (p=1.0; 0.77 and 0.86 for titanium, aluminum and vanadium ions 18 
respectively). Due to the high scattering of the metal ion content the power of 19 
the test for all ions was much lower than 80% (0.10 for Ti, 0.3 for V and 0.2 for 20 
Al).  21 
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Histology analysis of tissues and metal debris particles 1 
Histology analysis of the tissues isolated from patients with implanted 2 
sliding LSZ-4D devices all showed a similar appearance. There were regions 3 
which contained macrophages with large numbers of titanium particles. 4 
Individual particles could not be seen with light microscopy as they were of a 5 
small size. These macrophages often occurred in well vascularised tissue and 6 
there was an infiltration of plasma cells within the tissue. In other regions there 7 
was necrosis where the cell number was reduced and a-cellular regions of 8 
collagenous tissue were observed (Figure 5).  9 
Discussion 10 
We are reporting the incidence of metallosis associated complications that 11 
involved the formation of seromas and sinuses after implantation of titanium 12 
sliding growth guidance devices LSZ-4D in 5 of 25 patients. All cases of 13 
seromas and sinuses were observed in the lumbar part of the spine, which may 14 
be explained by the higher mobility of the lumbar spine region compared with 15 
the thoracic region.  16 
The observed frequency of metallosis associated complications (20%) is 17 
relatively high, regardless of the fact that only two of these five patients required 18 
revision surgery. However, the complication rates for other spinal 19 
instrumentation for scoliosis treatment in immature patients such as the growing 20 
rods or Shilla devices are also high [18-19] since the fusionless approach 21 
combined with periodic lengthening (growing rods) or sliding mechanisms 22 
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 14 
(Shilla or LSZ-4D) necessary for the retaining of spinal growth of pediatric 1 
patients makes the treatment more complex compared to that used for adult 2 
patients.  3 
Recent extensive analysis of metallosis associated complications for 4 
metal-on-metal total hip replacements made of CoCr alloys revealed positive 5 
correlation between the content of cobalt ions in patients’ blood and 6 
pseudotumors formation and implant loosening [11].  7 
Back in 1990s it was also revealed that patients with failed titanium-on-8 
polyethylene total knee and hip implants had several times higher titanium 9 
concentrations in their blood compared with subjects with normally functioning 10 
prostheses [12, 20]. Since increased levels of metal ions in patients’ blood were 11 
reported in literature even after fusion spine surgeries, we hypothesized that the 12 
implantation of fusionless, and especially sliding instrumentation would result in 13 
higher level of metal ions in the blood.  14 
Results of our study revealed that 90% of subjects in the study group with 15 
implanted LSZ-4D sliding devices had increased Ti and V ions levels in the 16 
blood. The amount of Ti and V ions in whole blood of these patients was 17 
increased 2.8 and 4 folds respectively compared with the control group of 18 
patients. No statistically significant difference was observed for aluminum 19 
content due the scattering of its content.  The content of vanadium ions in the 20 
blood is higher than that of titanium and does not reflect the ratio of these 21 
elements in titanium alloy composition which contains 6wt. % of Al and 4wt. % 22 
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 15 
of V, which is possibly due to the excretion of titanium from the body and the 1 
retention of vanadium.  2 
However, the increase of titanium content in the blood of patients after 3 
implantation of fusionless sliding LSZ-4D devices in our study is similar to 4 
values demonstrated by others who investigated patients with fusion devices. 5 
Cundy et al. revealed 2.4 folds elevated level of titanium in pediatric 6 
patients after fusion surgery (9 spine levels) [13]. Kasai et al. and Richardson at 7 
al. reported 4 fold and 3.6 fold increase in the adult patient’s blood with 8 
instrumentation implanted on 2 or 3 levels of lumbar spine [14-15]. Data, 9 
presented by Ipach et al also demonstrate 2-3 fold increases of titanium content 10 
in some adult patients with 5 fused segments [21]. Statistically significant 11 
correlation between the number of fused segments, length of rods, quantity of 12 
screws and content of titanium in the blood was not found by Richardson et al 13 
and Ipach et al. in their studies. However, the power of such comparisons in 14 
their studies might not be high due to the small number of patients in the tested 15 
subgroups [15, 21].  16 
Nevertheless, the number of operated spine segments might possibly be 17 
related to the number of patients who have increased Ti content. 90-95% of 18 
patients in our study (10-16 spine levels) and in that carried out by Cundy et al 19 
(9-10 spine levels) demonstrated increased Ti content [13]. In contrast, only 20 
35% and 65 % of subjects with up to 3 spine segments fused had increased 21 
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metal levels [14-15]. However, further studies with the same instrumentation 1 
would be necessary to support this hypothesis.  2 
Similar increase of Ti in patients’ blood demonstrated in previous studies 3 
and the absence of statistically significant difference in these metal content in 4 
the subgroup of patients who developed seromas and sinuses and those who did 5 
not (power 0.60 for Ti and V ions) might imply that the content of metal ions in 6 
the blood of patients with spinal instrumentation might not be used for the 7 
predicting of clinical complications such as seroma or sinus formation and the 8 
amount of wear debris generated by the spinal devices.  9 
Content of metal ions in the soft tissues adjacent to spinal implants is not 10 
extensively covered in literature. Wang et al. reported 30.36 g/g of titanium in 11 
tissues of patients who developed pseudarthrosis after previous lumbar 12 
decompression and fusion with titanium pedicle screw instrumentation 13 
surrounding titanium spinal instrumentation, while those with solid fusion had 14 
0.6 g/g [16]. In our study content of metal ions, especially titanium, in the 15 
tissues surrounding fixture-rod junction of sliding LSZ-4D device is 16 
dramatically higher being 1,300 g/g compared with 0.7 g/g observed in 17 
tissues collected from control group of subjects. Similar massive deposition of 18 
titanium debris (up to 3,700 g/g, average amount was 1047 g/g) was reported 19 
by Agins et al within tissues which surrounded failed total knee implants [22].  20 
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 17 
Our previous work has revealed that more than 50% of wear particles 1 
retrieved from tissues which surrounded LSZ-4D devices are less than 0.400 μm 2 
in size [23].  This is similar in size to that described for cobalt chromium and 3 
titanium wear particles retrieved from total hip replacements [24]. Histology 4 
observations of the tissues in this study revealed high content of metal debris, 5 
macrophages and even necrosis areas, which are often observed as an adverse 6 
inflammatory reaction of tissues to excessive metal debris after total hip 7 
replacements [25]. Based on these findings it might be assumed that high 8 
concentrations of titanium and vanadium ions in tissues surrounding sliding 9 
spinal implants LSZ-4D might possibly be the reason for such clinical 10 
manifestations as seromas and sinuses, some of which require surgical revision. 11 
Based on the results of this study, which revealed increased content of Ti 12 
and V ions in the blood of 90% of patients in the study group, high levels of 13 
metal content in the tissues around sliding device and cases of clinical 14 
complications like seromas and sinuses, it might be concluded that the additional 15 
efforts for improving the wear performance of growth guidance sliding 16 
instrumentation are necessary in order to fully exploit the benefits of such 17 
instrumentation. Since the biocompatibility of Ti is much higher compared to Co 18 
and Cr, which are present in CoCr and stainless steels, it might be hypothesized 19 
that the optimization of titanium instrumentation design and improvements in its 20 
wear resistance by the application of biocompatible wear resistant coatings 21 
would certainly be beneficial.  22 
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 18 
Limitations of the study. 1 
The limitation of this study is that our results are from a specific sliding 2 
device which has been used clinically. Although this device utilizes similar 3 
materials to those used in other spinal instrumentation the volume of wear 4 
debris released will be dependent upon the design and the way the rods are 5 
fixed. Nevertheless, our findings indicate the importance of using wear 6 
resistance materials for sliding and extending instrumentation which is used 7 
for the treatment of scoliosis in immature patients. It also indicates that 8 
replacement of the sliding and possibly extending devices in the spine after 9 
the completion of growth would be important as continual small cyclic 10 
movements may generate significant wear particle that have the potential to 11 
be problematic.  12 
 13 
Conclusions. 5 of 25 patients with implanted growth guidance sliding 14 
LSZ-4D devices made of titanium alloy Ti6Al4V developed metallosis 15 
associated complications. Two patients had sinuses and three had seromas in the 16 
lumbar part of the spine. Content of titanium and vanadium ions in the whole 17 
blood of 90% of patients with implanted LSZ-4D devices was increased 18 
compared with control group (2.8 and 4 times respectively) but did not exceed 19 
values reported previously in literature for fusion spinal instrumentation. Median 20 
content of titanium ions in soft tissues adjacent to implanted sliding device was 21 
measured to be more than 1,500 folds higher compared with control group, 22 
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 19 
which are much higher levels than previously reported for spinal 1 
instrumentation. No statistically significant difference in metal ion content in 2 
blood (power 0.60 for Ti and V ions) was revealed in patients with and without 3 
metallosis associated complications. Our findings imply that either the use of 4 
wear-resistant coatings on titanium alloy sliding devices or the use of a different 5 
material for such instrumentation would be beneficial.  6 
7 
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Figure captions 1 
Figure 1. Illustration of LSZ-4D sliding growth guidance device. Locked 2 
fixture is used at one spinal level. Unlocked fixtures are used at distal and 3 
proximal end of the device enabling sliding and continued spinal growth 4 
 5 
Figure 2. Content of titanium, aluminum and vanadium measured using ICP-6 
MS in the whole blood of patients for control group of patients (without 7 
implants) and study group (with implanted sliding LSZ-4D device for 6±2 8 
years). Box lengths represent the interquartile range (first to third quartiles). 9 
The line in the center of the boxes shows the median value. Data indicated 10 
by “o” are outliers (being more than 1.5 to 3.0 times the interquartile range 11 
over the third quartile), and data flagged by “*” are extreme values (more 12 
than 3 times the interquartile range over the third quartile). 13 
 14 
Figure 3. The intraoperative photograph shows the black discoloration of 15 
tissues in the lumbar part of the spine after disassembling of the sliding LSZ-16 
4D instrumentation at routine surgery to exchange this device with 17 
traditional fusion instrumentation when the child became skeletally mature 18 
(patient did not have any complications) 19 
 20 
Figure 4. Content of titanium, aluminum and vanadium measured using ICP-21 
MS method, in the soft tissues directly adjacent to fixture-rod junction in the 22 
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lumbar part of the spine for study group of patients (with implanted sliding 1 
LSZ-4D device for 6±2 years) and control group (without implants)  2 
 3 
Figure 5. Histology analysis of tissues surrounding LSZ-4D sliding device 4 
from patient without complications (A) and from patient developed seroma 5 
accompanied with elevated body temperature and increased erythrocyte 6 
sedimentation rate in the blood (B) showing densely stained tissue and 7 
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Table 1. Clinical information and metallosis related complications observed in 1 
the study group of patients with implanted LSZ-4D sliding devices  2 
Patient 
N 














1 Female 13 14 (T2-L4)  IIBN 5y 10m  
2 Female 12 10 (T4-L2)  IIBN 3y 6m  
3 Male 10 10 (T2-T12) IА+ 3y 6m  
4 Female 11 13 (T2-L3) IIBN 5y Fistula with inflammation 
(5 years after surgery) 
5 Female 12 14 (T2-L4) IIIBN 10y 1m Seroma, paleness, 
elevated body 
temperature, weight loss 
(10 years after surgery) 
6 Female 11 14 (T2-L4) IIICN 5y Seroma 
(1 year after surgery) 
7 Female 13 14 (T3-L5) IIICN 5y 5m Seroma, fistula without 
inflammation 
(2 years after surgery) 
8 Female 12 14 (T2-L4) IIBN 6y Seroma 
(6 months after surgery) 
9 Female 12 15 (T2-L5) IIIBN 10y  
10 Female 13 14 (T2-L4) IIICN 6y  
11 Female 10 14  (T2-L4) IIIBN 3y 6m  
12 Male 13 15 (T2-L5) IIICN 8y 3m  
13 Female 11 16 (T1-L5) IVCN  6y 3m  
14 Male 13 15 (T2-L5) IIIBN 5y 4m  
15 Female 10 14 (T2-L4) IIIBN 7y 4m  
16 Female 13 14 (T3-L5) IIICN 8y 2m  
17 Female 10 14 (T2-L4) IIICN 4y 2m  
18 Female 12 14 (T2-L4) IIIBN 5y 6m  
19 Female 11 10 (T4-L2) IIBN 4y 2m  
20 Female 10 14 (T2-L4) IIIBN 5y 6m  
21 Female 11 14 (T3-L5) VCN  5y 6m  
22 Female 10 14 (T2-L4) IIBN 4y 6m  
23 Female 12 14 (T2-L4) IIBN 5y 1m  
24 Female 11 15 (T2-L5) IIICN 4y 1m  
25 Female 10 10 (T2-T12) IBN  5y 3m  
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